VICAL INC (VICL)

Overview Price 3.50 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $3.50 Daily Range $0.00 - $0.00 52-Week Range $1.70 - $5.30 Volume 0 Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Other Resources for VICL Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs.   Brokerage Analyst Recommendations 6 Brokerage Firms Covering VICL   Strong Buy 4 Buy 0 Hold 2 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.67   VICL Ratings: BUY  SELL  HOLD VICL Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 9 Buy 1 Sell   Top Buy Analysis BUY: VICL Company: VICAL INCORPORATED Points: -11.14 Start Price: $3.14 Start Date: 12/19/2009 5:20 PM qwertz P&P Score: 0.56 Recs: as long as h1n1 is in the news... Comments: 0 | Comment More Recent Analysis Top Sell Analysis SELL: VICL Company: VICAL INCORPORATED Points: 35.26 Start Price: $6.16 Start Date: 01/01/2008 12:00 AM snowpusher P&P Score: 90.29 Recs: Comments: 0 | Comment More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	09/22/10	Sanofi Failure Opens Door for Aastrom Bio - Analyst Blog	0
Zacks_Analysts	0.00	12/30/09	Good News for Vical Candidate - Analyst Blog	0

Commentary

BUY: VICAL INCORPORATED (VICL) Start Price: $4.42 Points: -20.70 Created: 07/07/2011 Turning up from correction Comments: 0 | Comment wallstreeter Recs:

BUY: VICAL INCORPORATED (VICL) Start Price: $3.14 Points: -11.14 Created: 12/19/2009 as long as h1n1 is in the news... Comments: 0 | Comment qwertz Recs:

BUY: VICAL INCORPORATED (VICL) Start Price: $3.94 Points: -28.71 Created: 03/13/2010 Comments: 0 | Comment Shorty Recs:

SELL: VICAL INCORPORATED (VICL) Start Price: $6.16 Points: +35.26 Created: 01/01/2008 Comments: 0 | Comment snowpusher Recs:

BUY: VICAL INCORPORATED (VICL) Start Price: $7.27 Points: -43.94 Created: 01/01/2008 Comments: 0 | Comment rprimus Recs:

BUY: VICAL INCORPORATED (VICL) Start Price: $5.53 Points: -28.79 Created: 01/01/2008 Comments: 0 | Comment Krzyzanowski Recs:

BUY: VICAL INCORPORATED (VICL) Start Price: $5.82 Points: -31.94 Created: 01/01/2008 Comments: 0 | Comment 1armand Recs:

BUY: VICAL INCORPORATED (VICL) Start Price: $5.43 Points: -27.62 Created: 01/01/2008 Comments: 0 | Comment shanegk87 Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
wallstreeter	0.23	BUY	Six Months to a Year	07/07/2011	$4.42	$3.50 (-4.11%)	-20.81%	-0.11%	-20.70	view close
Shorty	99.67	BUY	Week to a Month	03/13/2010	$3.94	$3.50 (-4.11%)	-11.17%	+17.54%	-28.71
qwertz	0.56	BUY	Three to Six Months	12/19/2009	$3.14	$3.50 (-4.11%)	+11.46%	+22.60%	-11.14	view close
snowpusher	90.29	SELL	Six Months to a Year	01/01/2008	$6.16	$3.50 (-4.11%)	-43.18%	-7.92%	+35.26
rprimus	9.46	BUY	Six Months to a Year	01/01/2008	$7.27	$3.50 (-4.11%)	-51.86%	-7.92%	-43.94
Krzyzanowski	40.97	BUY	Six Months to a Year	01/01/2008	$5.53	$3.50 (-4.11%)	-36.71%	-7.92%	-28.79
1armand	40.97	BUY	Six Months to a Year	01/01/2008	$5.82	$3.50 (-4.11%)	-39.86%	-7.92%	-31.94
shanegk87	21.03	BUY	Six Months to a Year	01/01/2008	$5.43	$3.50 (-4.11%)	-35.54%	-7.92%	-27.62